HRMY
Harmony Biosciences Holdings, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +7.7% ·
share flow +1.7% ·
net new positions +7.1%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 113 | +5 | 37.66M | $1.37B | +12 | −6 |
| Q1 2026 | 110 | -3 | 39.20M | $1.10B | +5 | −9 |
| Q4 2025 | 114 | +1 | 39.01M | $1.46B | +2 | — |
| Q3 2025 | 20 | +1 | 24.69M | $680.58M | +2 | −2 |
| Q2 2025 | 17 | -1 | 23.07M | $729.13M | +1 | −2 |
| Q1 2025 | 15 | +1 | 6.74M | $223.55M | +1 | — |
| Q4 2024 | 14 | -1 | 7.61M | $261.77M | — | −1 |
| Q3 2024 | 14 | +1 | 3.56M | $142.57M | +1 | — |
| Q2 2024 | 13 | — | 3.50M | $105.70M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 735.42K | -1.8% | $29.42M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 735.42K | -1.8% | $29.42M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Renaissance Technologies ✦ | 492.60K | -17.3% | $19.70M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Norges Bank ✦ (passive) | 403.62K | +215.4% | $16.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | D. E. Shaw & Co. ✦ | 355.95K | +14.8% | $14.24M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 355.95K | +14.8% | $14.24M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Marshall Wace ✦ | 350.64K | +14.7% | $14.03M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Marshall Wace ✦ | 350.64K | +14.7% | $14.03M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Arrowstreet Capital ✦ | 317.57K | New | $12.70M | 0.0% | New | 1 | SEC ↗ |
| 10 | Adage Capital Partners ✦ | 300.00K | +500.0% | $12.00M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 154.68K | -77.4% | $6.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 154.68K | -77.4% | $6.19M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Two Sigma Investments ✦ | 143.00K | +53.2% | $5.72M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 142.59K | -7.6% | $5.70M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 142.59K | -7.6% | $5.70M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 142.59K | -7.6% | $5.70M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Millennium Management ✦ | 70.81K | -77.0% | $2.83M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Gotham Asset Management ✦ | 66.72K | -21.5% | $2.67M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Wellington Management ✦ | 15.64K | -40.1% | $625,680 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | Wellington Management ✦ | 15.64K | -40.1% | $625,680 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | Wellington Management ✦ | 15.64K | -40.1% | $625,680 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | Wellington Management ✦ | 15.64K | -40.1% | $625,680 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | T. Rowe Price ✦ | 14.88K | +1.3% | $596,000 | 0.0% | ▲ Add | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Arrowstreet Capital | $12.70M | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 306 holders, 54.70M shares, $1.38B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.